KORU Medical Systems, Inc. (NASDAQ:KRMD – Get Free Report) saw a significant increase in short interest in the month of October. As of October 15th, there was short interest totalling 504,300 shares, an increase of 10.3% from the September 30th total of 457,400 shares. Based on an average daily trading volume, of 68,500 shares, the days-to-cover ratio is presently 7.4 days. Approximately 1.2% of the company’s stock are short sold.
Analyst Upgrades and Downgrades
Several brokerages recently issued reports on KRMD. Piper Sandler upped their target price on KORU Medical Systems from $2.50 to $3.00 and gave the company an “overweight” rating in a research report on Thursday, August 8th. B. Riley began coverage on KORU Medical Systems in a research report on Thursday, July 25th. They issued a “buy” rating and a $4.00 price objective for the company.
Check Out Our Latest Stock Analysis on KRMD
Hedge Funds Weigh In On KORU Medical Systems
KORU Medical Systems Stock Performance
Shares of KRMD stock traded up $0.29 during mid-day trading on Thursday, hitting $2.92. 51,234 shares of the stock were exchanged, compared to its average volume of 117,726. The stock has a market capitalization of $133.90 million, a price-to-earnings ratio of -10.43 and a beta of 0.42. The stock’s fifty day simple moving average is $2.55 and its two-hundred day simple moving average is $2.41. The company has a debt-to-equity ratio of 0.01, a quick ratio of 3.27 and a current ratio of 3.77. KORU Medical Systems has a 12-month low of $1.98 and a 12-month high of $3.09.
KORU Medical Systems (NASDAQ:KRMD – Get Free Report) last announced its quarterly earnings data on Wednesday, August 7th. The company reported ($0.02) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.04) by $0.02. The company had revenue of $8.43 million for the quarter, compared to analysts’ expectations of $7.52 million. KORU Medical Systems had a negative net margin of 38.16% and a negative return on equity of 20.82%. During the same period in the previous year, the company posted ($0.05) EPS. On average, analysts forecast that KORU Medical Systems will post -0.13 EPS for the current year.
About KORU Medical Systems
KORU Medical Systems, Inc develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria.
Featured Stories
- Five stocks we like better than KORU Medical Systems
- Industrial Products Stocks Investing
- Microsoft Can Hit New All-Time Highs This Year – Here’s Why
- What is the S&P/TSX Index?
- Zillow Stock’s Bull Case: Why This Recent Sell-Off Could Be a Buy
- What is a Low P/E Ratio and What Does it Tell Investors?
- IonQ’s Quantum Surge: Ride the Wave or Cash Out?
Receive News & Ratings for KORU Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for KORU Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.